Comments
Loading...

Teva Pharmaceutical Indus

TEVANYSE
Logo brought to you by Benzinga Data
$17.88
0.030.17%
At Close: -
$17.94
0.060.34%
After Hours: 6:02 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$26.00
Lowest Price Target1
$10.00
Consensus Price Target1
$17.00

Teva Pharmaceutical Indus (NYSE:TEVA) Stock, Analyst Ratings, Price Targets, Forecasts

Teva Pharmaceutical Industries Ltd has a consensus price target of $17 based on the ratings of 13 analysts. The high is $26 issued by UBS on September 3, 2024. The low is $10 issued by Morgan Stanley on May 25, 2023. The 3 most-recent analyst ratings were released by UBS, Barclays, and UBS on September 3, 2024, August 1, 2024, and July 10, 2024, respectively. With an average price target of $24 between UBS, Barclays, and UBS, there's an implied 33.78% upside for Teva Pharmaceutical Industries Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
2
May
1
Jun
0
0
0
0
Jul
1
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS
Barclays
Jefferies
B of A Securities
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Teva Pharmaceutical Indus

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Teva Pharmaceutical Indus (TEVA) stock?

A

The latest price target for Teva Pharmaceutical Indus (NYSE:TEVA) was reported by UBS on September 3, 2024. The analyst firm set a price target for $26.00 expecting TEVA to rise to within 12 months (a possible 44.93% upside). 18 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Teva Pharmaceutical Indus (TEVA)?

A

The latest analyst rating for Teva Pharmaceutical Indus (NYSE:TEVA) was provided by UBS, and Teva Pharmaceutical Indus maintained their buy rating.

Q

When was the last upgrade for Teva Pharmaceutical Indus (TEVA)?

A

The last upgrade for Teva Pharmaceutical Industries Ltd happened on March 8, 2024 when JP Morgan raised their price target to $14. JP Morgan previously had an underweight for Teva Pharmaceutical Industries Ltd.

Q

When was the last downgrade for Teva Pharmaceutical Indus (TEVA)?

A

The last downgrade for Teva Pharmaceutical Industries Ltd happened on January 19, 2023 when Jefferies changed their price target from $10 to $12 for Teva Pharmaceutical Industries Ltd.

Q

When is the next analyst rating going to be posted or updated for Teva Pharmaceutical Indus (TEVA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teva Pharmaceutical Indus, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teva Pharmaceutical Indus was filed on September 3, 2024 so you should expect the next rating to be made available sometime around September 3, 2025.

Q

Is the Analyst Rating Teva Pharmaceutical Indus (TEVA) correct?

A

While ratings are subjective and will change, the latest Teva Pharmaceutical Indus (TEVA) rating was a maintained with a price target of $24.00 to $26.00. The current price Teva Pharmaceutical Indus (TEVA) is trading at is $17.94, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch